108 related articles for article (PubMed ID: 15582419)
1. Amide derivatives of 9,11-seco-estra-1,3,5(10)-trien-11-oic acid as modified orally active estrogen agonists with moderate antagonistic activity.
Negi AS; Chaturvedi D; Gupta A; Ray S; Dwivedy A; Singh MM
Bioorg Med Chem Lett; 2005 Jan; 15(1):99-102. PubMed ID: 15582419
[TBL] [Abstract][Full Text] [Related]
2. Synthesis and structure guided evaluation of estrogen agonist and antagonist activities of some new tetrazolyl indole derivatives.
Singh US; Shankar R; Yadav GP; Kharkwal G; Dwivedi A; Keshri G; Singh MM; Moulik PR; Hajela K
Eur J Med Chem; 2008 Oct; 43(10):2149-58. PubMed ID: 18155810
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of estrone sulfate-induced uterine growth by potent nonestrogenic steroidal inhibitors of steroid sulfatase.
Ciobanu LC; Luu-The V; Martel C; Labrie F; Poirier D
Cancer Res; 2003 Oct; 63(19):6442-6. PubMed ID: 14559834
[TBL] [Abstract][Full Text] [Related]
4. Synthesis, estrogen receptor binding affinity and biological evaluation of some 2-substituted estrone derivatives.
Omar AM; AboulWafa OM; Labouta IM; el-Tombary AA; el-Mallah AI
Farmaco; 1997 Apr; 52(4):219-25. PubMed ID: 9241826
[TBL] [Abstract][Full Text] [Related]
5. Synthesis of 4-formyl estrone using a positional protecting group and its conversion to other C-4-substituted estrogens.
Liu Y; Kim B; Taylor SD
J Org Chem; 2007 Nov; 72(23):8824-30. PubMed ID: 17929872
[TBL] [Abstract][Full Text] [Related]
6. Heteroatom-substituted analogues of the active-site directed inhibitor estra-1,3,5(10)-trien-17-one-3-sulphamate inhibit estrone sulphatase by a different mechanism.
Woo LW; Lightowler M; Purohit A; Reed MJ; Potter BV
J Steroid Biochem Mol Biol; 1996 Jan; 57(1-2):79-88. PubMed ID: 8645620
[TBL] [Abstract][Full Text] [Related]
7. Amide derivatives of 2,3-diarylacrylophenone as estrogen receptor binding ligands.
Gupta A; Raghunandan R; Kumar A; Maulik PR; Dwivedy A; Keshri G; Singh MM; Ray S
Med Chem; 2007 May; 3(3):241-53. PubMed ID: 17504195
[TBL] [Abstract][Full Text] [Related]
8. Contraceptive and hormonal properties of the stem bark of Dysoxylum binectariferum in rat and docking analysis of rohitukine, the alkaloid isolated from active chloroform soluble fraction.
Keshri G; Oberoi RM; Lakshmi V; Pandey K; Singh MM
Contraception; 2007 Nov; 76(5):400-7. PubMed ID: 17963866
[TBL] [Abstract][Full Text] [Related]
9. [Synthesis and study of B-nor-8-isoanalogs of steroid estrogens].
Shavva AG; Selivanov SI; Starova GL; Boronoeva TR; Ishchenko IV; Gluzdikov IA; Sharetskiĭ AN; Isaeva VG; Surinov BP
Bioorg Khim; 2002; 28(3):242-50. PubMed ID: 12077850
[TBL] [Abstract][Full Text] [Related]
10. Novel, potent inhibitors of 17beta-hydroxysteroid dehydrogenase type 1.
Allan GM; Bubert C; Vicker N; Smith A; Tutill HJ; Purohit A; Reed MJ; Potter BV
Mol Cell Endocrinol; 2006 Mar; 248(1-2):204-7. PubMed ID: 16337736
[TBL] [Abstract][Full Text] [Related]
11. Influence of alkyl group on amide nitrogen atom on fluorescence quenching of tyrosine amide and N-acetyltyrosine amide.
Mrozek J; Rzeska A; Guzow K; Karolczak J; Wiczk W
Biophys Chem; 2004 Oct; 111(2):105-13. PubMed ID: 15381308
[TBL] [Abstract][Full Text] [Related]
12. Modulation of estrogen action during preimplantation period and in immature estradiol-primed rat uterus by anti-implantation agent, ormeloxifene.
Dwivedi A; Basu R; Chowdhury SR; Goyal N
Contraception; 2005 Jun; 71(6):458-64. PubMed ID: 15914137
[TBL] [Abstract][Full Text] [Related]
13. Anti-implantation effect of droloxifene in rats and its relationship with anti-estrogenic activity.
Huang Y; Shen Y; Feng Y; Cao L; Leng Y
Acta Pharmacol Sin; 2005 Oct; 26(10):1243-7. PubMed ID: 16174441
[TBL] [Abstract][Full Text] [Related]
14. Synthesis and molecular structure of 14,15-pyrrolidino-and 14,16-ethano derivatives of estrone.
Baranovsky AV; Bolibrukh DA; Bull JR; Lyakhov AS; Khripach VA
Steroids; 2008 Jul; 73(6):585-93. PubMed ID: 18325556
[TBL] [Abstract][Full Text] [Related]
15. Influence of modified transdermal hormone replacement therapy on the concentrations of hormones, growth factors, and bone mineral density in women with osteopenia.
Stanosz S; Zochowska E; Safranow K; Sieja K; Stanosz M
Metabolism; 2009 Jan; 58(1):1-7. PubMed ID: 19059524
[TBL] [Abstract][Full Text] [Related]
16. An analog of doisynolic acid. 3-Hydroxy-16,17-seco-16-norestra-1,3,5(10)-trien-17-oic acid.
Bielefeld MA; Oslapas R
J Med Chem; 1969 Jan; 12(1):192-5. PubMed ID: 5763032
[No Abstract] [Full Text] [Related]
17. Estradiol and estrone C-16 derivatives as inhibitors of type 1 17beta-hydroxysteroid dehydrogenase: blocking of ER+ breast cancer cell proliferation induced by estrone.
Laplante Y; Cadot C; Fournier MA; Poirier D
Bioorg Med Chem; 2008 Feb; 16(4):1849-60. PubMed ID: 18035543
[TBL] [Abstract][Full Text] [Related]
18. Estrogenic activity of 37 components of commercial sunscreen lotions evaluated by in vitro assays.
Morohoshi K; Yamamoto H; Kamata R; Shiraishi F; Koda T; Morita M
Toxicol In Vitro; 2005 Jun; 19(4):457-69. PubMed ID: 15826804
[TBL] [Abstract][Full Text] [Related]
19. Synthesis and in vivo evaluation of 11-substituted estradiol derivatives as anti-implantation agents.
Dwivedy I; Gupta A; Grover A; Srivastava V; Singh MM; Ray S
Bioorg Med Chem Lett; 2008 Jul; 18(14):4102-5. PubMed ID: 18550371
[TBL] [Abstract][Full Text] [Related]
20. Enaminone amides as novel orally active GABAA receptor modulators.
Hogenkamp DJ; Johnstone TB; Huang JC; Li WY; Tran M; Whittemore ER; Bagnera RE; Gee KW
J Med Chem; 2007 Jul; 50(14):3369-79. PubMed ID: 17571865
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
